American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Donate
Your AHNS Member Panel

Jeffrey Janus – Jacksonville, Florida

Published on by Jeffrey Janus

Practice Contact Information

Mayo Clinic Florida
4500 San Pablo Road South

Jacksonville
Florida
32224
United States

Phone: 904-953-6674
Email:
Web Site: https://www.mayoclinic.org/biographies/janus-jeffrey-r-m-d/bio-20097323

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

I am the current chairman of the Otolaryngology Department at Mayo Clinic Florida; a group that delivers excellent care to patients and which am very honored to be part of. My practice is 100% head and neck oncology, endocrine, and reconstructive surgery. I pride myself on treating patients how I would want to be treated: with care, compassion, and candor.

Clinical Trials

Bibliography

Dr. Jeffrey R. Janus is currently the Chair of the Department of Otolaryngology at Mayo Clinic in Jacksonville, Florida. He is a board certified, fellowship trained, Head and Neck Oncologic and Reconstructive Surgeon. Dr. Janus trained at the University of Florida College of Medicine in Gainesville, Florida where he received entrance into the Junior Honors Medical Program, combining the last year of undergraduate training and the first year of medical school. He was at the Mayo Clinic in Rochester, Minnesota from 2008-2019 as an Otolaryngologist, Head and Neck Surgeon. In early 2020, Dr. Janus transferred to Mayo Clinic Florida to continue his work. Dr. Janus’s interests include:

  • Salivary tumor (Parotid Gland) Surgery with special focus on postoperative facial nerve function and aesthetics
  • Removal and reconstruction of Head and Neck Cancers with concentration on restoration of pre-morbid form and function. These cases are often done with preoperative 3D planning and 3D printing of patient specific tools.
  • Endocrine Surgery — removal of thyroid and parathyroid tumors with consideration of voice function
  • Robotic Surgery — the use of the surgical robot to remove tumors of the throat (oropharynx) and voice box (larynx)
  • Multidisciplinary Head and Neck Cancer Clinic — this is a group of Head and Neck Surgeons, Radiation Oncologists, Medical Oncologists, Pathologists, Radiologists, and other staff who meet regularly at Mayo Clinic Florida to review complex cases and compose multidisciplinary treatment plans.
  • Minimally invasive (endoscopic) approaches to the skull base and pituitary gland

In addition to his clinical activities, Dr. Janus’ is active in research and education, providing mentorship to residents and fellows. He authors expert content and publishes in high-impact scientific journals and actively collaborates with the center for regenerative medicine and the cancer center.

Daniel Kwon – Los Angeles, CA

Published on by Daniel Kwon

Practice Contact Information

Keck Medicine, University of Southern California
1450 San Pablo Street, Suite 5800

Los Angeles
CA
90033
United States

Phone: 3238656145
Email: [email protected]
Web Site: https://providers.keckmedicine.org/provider/Daniel+Injung+Kwon/1103027

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Daniel Kwon, MD, is board-certified and fellowship-trained in all
areas of head and neck cancer surgery. His clinical practice ranges
from minimally invasive transoral robotic and laser microsurgery
for early-stage tumors to microvascular free flap reconstruction or
salvage surgery for advanced and recurrent cancers.

Additionally, his practice focuses on Thyroid and Parathyroid
surgery and he co-directs the USC Thyroid Cancer Program as well
as the Children’s Hospital of Los Angeles Thyroid Cancer group. He
is one of the highest volume thyroid and parathyroid surgeons in
Los Angeles.

Clinical Trials

Bibliography

Andrew Larson – Burlington, Massachusetts

Published on by Andrew Larson

Practice Contact Information

Lahey Hospital And Medical Center/Boston University
41 Burlington Mall Road

Burlington
Massachusetts
01805
United States

Phone: 781.744.8450
Email: [email protected]
Web Site: https://physicians.lahey.org/details/4420/andrew-larson-otolaryngology_ear_nose__throat-burlington

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Dr. Larson is a Head and Neck Oncologic/Reconstructive Surgeon at Lahey Hospital and Medical Center in Burlington, MA, and has an academic appointment as Assistant Professor at Boston University School of Medicine.  He received his medical degree from the University of California, San Francisco, and also completed residency training in Otolaryngology-Head and Neck Surgery at the University of California, San Francisco.  He completed a fellowship in Head and Neck Oncologic, Skull Base, and Microvascular Reconstructive Surgery at Massachusetts Eye and Ear in Boston, MA.  Dr. Larson has extensive training in transoral robotic surgery, microvascular head and neck reconstruction, thyroid and parathyroid surgery, and surgeon-person ultrasound.

Clinical Trials

Bibliography

  1. Larson AR, Ryan WR. Transoral Excision of Parapharyngeal Space Tumors. Otolaryngol Clin North Am. 2021 June; doi:10.1016/j.otc.2021.03.001. PMID: 34024481.
  2. Larson AR, Kong KA, Walvekar RR, Ryan WR. Obstructive Sialadenitis: Stones and Stenosis.  Curr Otorhinolaryngol Rep. Published online 2021:1-8. doi:10.1007/s40136-021-00339-5.
  3. Larson AR, Han M, Webb KL, et al. Patient-Reported Outcomes of Split-Thickness Skin Grafts for Floor of Mouth Cancer Reconstruction. ORL. Published online 2021:1-8. doi:10.1159/000512085. PMID: 33582667.
  4. Stanford-Moore GB, Ochoa E, Larson AR, Han M, Hoppe K, Ryan WR. Patterns of Nodal Metastases and Predictors of Occult Disease in HPV-Associated Oropharynx Cancer. Otolaryngol Head Neck Surg. 2020 Sept; doi: 10.1177/0194599820951473.
  5. Ochoa E, Larson AR, Han M, Webb KL, Stanford-Moore G, El-Sayed IH, George JR, Ha PK, Heaton CM, Ryan WR. Patient-reported Quality of Life After Resection with Primary Closure for Oral Tongue Carcinoma.   2020 May 7; doi: 10.1002/lary.28723. PMID: 32379355.
  6. Formeister EJ, Baum R, Knott PD, Seth R, Ha P, Ryan W, El-Sayed I, George J, Larson AR, Plonowska K, Heaton C. Machine Learning for Predicting Complications in Head and Neck Microvascular Free Tissue Transfer. Laryngoscope. 2020 Jan 28. PMID: 31990084.
  7. Han M, Stanford-Moore GB, Larson AR, Schoppy DW, Cognetti DM, Joshi AS, Houlton JJ, Ryan WR. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone. Laryngoscope. 2019 Nov 1;. doi: 10.1002/lary.28344.  PMID: 31675132.
  8. Larson AR, Kemmer J, Formeister E, El-Sayed I, Ha P, George J, Ryan W, Chan E, Heaton C. Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma. Laryngoscope. 2019 Aug 14;doi: 10.1002/lary.28241. PMID: 31411752.
  9. Larson AR, Aubin-Pouliot A, Delagnes E, Zheng M, Chang JL, Ryan WR. Surgeon-Performed Ultrasound for Chronic Obstructive Sialadenitis Helps Predict Sialendoscopic Findings and Outcomes. Otolaryngol Head Neck Surg. 2017 Dec;157(6):973-980. PMID: 28871894.
  10. Niethamer TK, Larson AR, O’Neill AK, Bershteyn M, Hsiao EC, Klein OD, Pomerantz JH, Bush JO. EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells. Stem Cell Reports. 2017 Feb 22. PMID: 28238796.
  11. O’Neill AK, Kindberg AA, Niethamer TK, Larson A, Ho HH, Greenberg ME, Bush JO. Unidirectional Eph/ephrin signaling creates a cortical actomyosin differential to drive cell segregation. J Cell Biol. 2016 Oct 24; 215(2):217-229. PMID: 27810913.
  12. Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, Barani IJ, James CD, Parsa AT. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol. 2014 May; 16(5):628-36. PMID: 24696499; PMCID: PMC3984561.

Evan Greenbaum – Chicago, IL

Published on by Evan Greenbaum

Practice Contact Information

John Stroger Hospital of Cook County
1950 W. Polk
7th Floor
Chicago
IL
60612
United States

Phone:
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

I focus on providing patient-centered, individually-tailored, contemporary care for patients across the breadth of otolaryngology.

Clinical Trials

Bibliography

Carol Bier-Laning – Maywood, Illinois

Published on by Carol Bier-Laning

Practice Contact Information

Loyola University Medical Center
2160 South 1st Avenue

Maywood
Illinois
60153
United States

Phone: 708-327-3315
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

I practice head and neck surgical oncology with a patient-centered, team approach. I believe in listening to patients and guiding treatment based on their wishes coupled with an evidence-based approach. My skills include traditional open approaches to benign and malignant tumors of the upper aerodigestive tract, skin, salivary glands, sinuses and thyroid as well as minimally invasive procedures including transoral robotic surgery (TORS), transoral laser microsurgery (TLM) and salivary endoscopy.

Clinical Trials

Bibliography

  1. Cooper DMF, Bier-Laning CM, Halford MK, Ahlijanian MK, Zahniser NR. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependant process. Mol Pharmacol 1986;29:113-119
  2. Zahniser NR, Parker DC, Bier-Laning CM, Miller JA, Gerber JG, Nies AS. Comparison between the effects of aging on antagonist and agonist interactions with beta-adrenergic receptors on human mononuclear and polymorphonuclear leukocyte membranes. J Gerontol 1988;43:151-157.
  3. Zahniser NR, Bier-Laning CM, Gerber JG, Nies AS. Timolol-induced up gulation of polymorphonuclear leukocyte b2-adrenergic receptors in the elderly. Clin Pharmacol Ther 1989;45:469-75.
  4. Hitzemann R, Dains K, Bier-Laning CM, Zahniser NR. On the selection of mice  for haloperidol response and non-response. Psychopharmacol 1991;103:244-250. Note typographical error of Bier-Langing CM in article title.
  5. Bier-Laning CM, Adams GL. Patterns of recurrence after CO2 laser excision of intraoral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1995; 121 :1239-1244.
  6. Bier-Laning CM, Hom DB, Gapany M, Manivel JC, Duvall AJ III. Microcystic adnexal carcinoma: Management options based on long-term follow-up. Laryngoscope 1995;105:1197-1201.
  7. Schuller DE, Mountain RE, Nicholson RE, Bier-Laning CM, Powers B, Repasky M. One stage reconstruction of partial laryngopharyngeal defects. Laryngoscope 1997;107:247-253.
  8. Schuller DE, Bier-Laning CM. Laryngeal carcinoma nodal metastases and their management. Otolaryngol Clinics North Am 1997;30:167-177.
  9. Schuller DE, Bier-Laning CM, Sharma PK, Siegle RJ, Pellegrini AE, Karanfilov B, Bellisari G, Miller R, Young DC. Tissue conserving surgery for prognosis, treatment, and function preservation. Laryngoscope 1998;108:1599-1604.
  10. Danahey DG. Tobin EJ. Schuller DE. Bier-Laning CM. Weghorst CM. Lang JC. p16 mutation frequency and clinical correlation in head and neck cancer. Acta Oto-Laryngologica 1999;119:285-8.
  11. Kim LT, Wu J, Bier-Laning CM, Dollar BT, Turnage RH. Focal adhesion kinase up-regulation and signaling in activated keratinocytes. J Surg Res 2000;91:65-69.
  12. Banich J, Reyes CV, Bier-Laning CM. Sebaceous lymphadenoma identified by fine needle aspiration biopsy. Acta Cytologica 2007;51:211-3.
  13. Bier-Laning CM, Durazo-Arvizu R, Muzaffar K, Petruzzelli GJ. Primary tumor thickness as a risk factor for contralateral cervical metastases in T1/T2 oral tongue squamous cell carcinoma. Laryngoscope. 2009;119:883-8.
  14. Jaber JJ, Moreira J, Canar WJ, Bier-Laning CM. 25 Year Analysis of Veterans Treated for Tonsillar Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg. 2009;135:1147-53.
  15. Du N, Baker PM, Do TU, Bien C, Bier-Laning CM, Singh S, Shih SJ, Diaz MO, Vaughan AT. 11q21.1-11q23.3 is a site of intrinsic genomic instability triggered by irradiation. Genes, Chromosomes and Cancer.   2010;49:831-43.
  16. Yang SF, Bier-Laning CM (co-first authors), Adams W, Zilliox MJ. Candidate Biomarkers for HPV Negative Head and Neck Cancer Identified Via Gene Expression Barcode Analysis. Otolaryngol Head Neck Surg. 2016 Apr 19 [Epub ahead of print].
  17. Vashi P, Abboud E, Bier-Laning CM, Gupta D. Adult-onset Kaposiform Hemangioendothelioma of the Tongue: A Case Report. Curr Oncol. 2016;23(5):e517-e520.
  18. Bier-Laning CM, Hotaling J, Canar WJ, Ansari AA. Survival, Outcomes, and Use of Acuity Scoring Systems Following Tracheotomy in Veteran Patients. Am J Hosp Palliat Care. 2020 Nov;37(11):890-896. [Epub 2020 Mar 30].
  19. Ander M, Yang S, Thorpe E, Goyal A, Bier-Laning C. Elective Tracheotomy in COVID-19 Patients: A Team-Based Approach. Anesth Analg. 2020 Jul 7 [Online ahead of print].
  20. Bier-Laning CM, Cramer JD, Roy S, et al. Tracheostomy during COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries. Otolaryngol Head Neck Surg. 2020 Nov 3. Epub ahead of print.Roy S, Cramer JD,
  21. Bier-Laning C, Palmieri PA, Rassekh CH, Brenner MJ. Emergency Surgical Airway Algorithm for Difficult Airway Management During the COVID-19 Pandemic. Otolaryngol Head Neck Surg. 2021 Jan 26. Epub ahead of print.